Ren et al. showed that ME2 knockdown in two melanoma cell lines reduced in vitro growth rates, anchorage-independent clonogenicity, in vivo xenograft growth and basal ATP levels while also activating AMPK [223,224]. The gene discussed is ME2; the disease is melanoma.